News
Innobiochips made a significant impact at Medfit 2025, affirming its position as a leader in innovation within the In Vitro Diagnostics (IVD) field.
Innobiochips is constantly refreshing its specific know-how in order to cope with the strict regulations for IVD in Europe (IVDR).
Driven by its unique expertise in biology and biochemistry, Innobiochips develops breakthrough solutions that significantly improve the accuracy and productivity of in vitro diagnostic approaches.
The Innobiochips Scientific Advisory Board includes both top-level scientists and representatives of users and manufacturers in the diagnostic sector.
The agreement allows BAG Diagnostics to integrate Innobiochips' proprietary SirYus technology into its Histo Spot product line.